0001225208-18-000492.txt : 20180103 0001225208-18-000492.hdr.sgml : 20180103 20180103195315 ACCESSION NUMBER: 0001225208-18-000492 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180101 FILED AS OF DATE: 20180103 DATE AS OF CHANGE: 20180103 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mirviss Jeffrey B. CENTRAL INDEX KEY: 0001566094 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-11083 FILM NUMBER: 18508001 MAIL ADDRESS: STREET 1: C/O BOSTON SCIENTIFIC CORPORATION STREET 2: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BOSTON SCIENTIFIC CORP CENTRAL INDEX KEY: 0000885725 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 042695240 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 BUSINESS PHONE: 508-683-4000 MAIL ADDRESS: STREET 1: 300 BOSTON SCIENTIFIC WAY CITY: MARLBOROUGH STATE: MA ZIP: 01752-1234 4 1 doc4.xml X0306 4 2018-01-01 0000885725 BOSTON SCIENTIFIC CORP BSX 0001566094 Mirviss Jeffrey B. 300 BOSTON SCIENTIFIC WAY MARLBOROUGH MA 01752-1234 1 SVP&Pres, Periph Intervent Common Stock 2017-11-21 5 G 0 35.0000 0.0000 D 78640.0000 D Common Stock 2017-11-22 5 G 0 150.0000 0.0000 D 78490.0000 D Common Stock 2017-11-27 5 G 0 135.0000 0.0000 D 78355.0000 D Common Stock 2018-01-01 4 M 0 11673.0000 0.0000 A 90028.0000 D Common Stock 2018-01-01 4 F 0 4171.0000 24.7900 D 85857.0000 D Performance Share Units 2018-01-01 4 M 0 11673.0000 0.0000 D 2017-12-31 2017-12-31 Common Stock 11673.0000 0.0000 D Includes shares acquired under the Boston Scientific Global Employee Stock Purchase Plan based upon the most current data available. On February 23, 2015, the reporting person was awarded a target number of performance share units under the Company's 2015 Free Cash Flow Performance Share Program, the actual number of which to be earned by the reporting person based on the Company's 2015 adjusted free cash flow measured against its 2015 financial plan over the one-year performance period ending December 31, 2015 and subject to the completion of a three-year individual service period (inclusive of the performance period). On February 22, 2016, the number of the target performance share units as to which the performance criteria had been satisfied was determined. The performance share units so determined vested in whole upon the completion of the individual service period that ended on December 31, 2017. Each performance share unit represents the Company's commitment to issue one share of Boston Scientific common stock. /s/ Vance R. Brown, Attorney-in-fact 2018-01-03